Luye Pharma Group Ltd.
LYPHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $313 | $451 | $388 | $383 |
| Dep. & Amort. | $408 | $442 | $348 | $370 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7 | $11 | $10 | $10 |
| Change in WC | $888 | -$19 | -$1,215 | $79 |
| Other Non-Cash | $169 | -$324 | $74 | $63 |
| Operating Cash Flow | $1,784 | $562 | -$394 | $906 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$596 | $0 | -$633 |
| Net Acquisitions | $0 | -$634 | $0 | $0 |
| Inv. Purchases | $0 | -$2,390 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $3,561 | $0 | $0 |
| Other Inv. Act. | -$267 | -$907 | -$505 | -$708 |
| Investing Cash Flow | -$267 | -$966 | -$505 | -$1,340 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,462 | $1,876 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$879 | $100 | $980 | -$681 |
| Financing Cash Flow | $584 | $1,976 | $980 | -$681 |
| Forex Effect | -$102 | $25 | $20 | -$118 |
| Net Chg. in Cash | $6,936 | $4,887 | $50 | -$617 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $50 | $0 | $0 |
| End Cash | $6,936 | $4,937 | $50 | -$617 |
| Free Cash Flow | $1,784 | -$1,146 | -$394 | $273 |